Control of Mycobacterium fortuitum and Mycobacterium intracellulare infections with respect to distinct granuloma formations in livers of BALB/c mice

Memorias do Instituto Oswaldo Cruz

Volumn 105, Issue 5, 2010, Pages 642-648

  da Silva, Tânia Regina Marques ^a   Petersen, Antonio Luis de Oliveira Almeida ^a   Santos, Theo de Araújo ^a   de Almeida, Taís Fontoura ^a   de Freitas, Luiz Antônio Rodrigues ^a   Veras, Patrícia Sampaio Tavares ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Control of infection; Granuloma; Liver; Mycobacterium fortuitum; Mycobacterium intracellulare

Indexed keywords

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MUS; MYCOBACTERIUM; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM INTRACELLULARE;

EID: 77957220957     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762010000500007     Document Type: Article

References (35)

1. Algood HM, Lin PL, Flynn JL 2005. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infec Dis 41 (Suppl. 3): S189-S193.
2. Alvarez-Uria G 2010. Lung disease caused by nontuberculous mycobacteria. Curr Opin Pulm Med 16: 251-256.
3. Appelberg R, Castro AG, Pedrosa J, Silva RA, Orme IM, Minóprio P 1994. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and dependent phases of Mycobacterium avium infection. Infect Immun 62: 3962-3971.
4. ATS - American Thoracic Society 1997. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 156: 1-25.
5. Bouley DM, Ghori N, Mercer KL, Falkow S, Ramakrishnan L 2001. Dynamic nature of host-pathogen interactions in Mycobacterium marinum granulomas. Infect Immun 69: 7820-7831.
6. Brennan PJ 2003. Structure, function and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis (Edinb) 83: 91-97.
7. Brown-Elliott BA, Wallace RJ Jr 2005. Infections caused by nontuberculous mycobacteria. In GL Mandell, JC Bennett, R Dolin (eds.), Mandell, Douglas and Bennett's: Principles and practice of infectious diseases, Vol. 2, 6th ed., Elsevier, Philadelphia, p. 2909-2916.
8. Chan ED, Bai X, Kartalija M, Orme IM, Ordway DJ 2010. Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease. Am J Respir Cell Mol Biol: in press.
9. Chatterjee D, Khoo KH 1998. Mycobacterial lipoarabinomannan: an extraordinary lipoheteroglycan with profound physiological effects. Glycobiology 8: 113-120.
10. Da Silva TR, De Freitas JR, Silva QC, Figueira CP, Roxo E, Leão SC, De Freitas LA, Veras PS 2002. Virulent Mycobacterium fortuitum restricts NO production by a gamma interferon-activated J774 cell line and phagosome-lysosome fusion. Infect Immun 70: 5628-5634.
11. Denis M, Forget A, Pelletier M, Turcotte R, Skamene E 1986. Control of Bcg gene of early resistance in mice to infections with BCG substrains and atypical mycobacteria. Clin Exp Immunol 63: 517-525.
12. Flynn JL, Scanga CA, Tanaka KE, Chan J 1998. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 160: 1796-1803.
13. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K 2007. An official ATS/IDSA statement: diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175: 367-416.
14. Hänsch HC, Smith DA, Mielke ME, Hahn H, Bancroft GJ, Ehlers S 1996. Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int Immunol 8: 1299-1310.
15. Hein J, Schellenberg U, Bein G, Hackstein H 2001. Quantification of murine IFN-gamma mRNA and protein expression: impact of real-time kinetic RT-PCR using SYBR green I dye. Scand J Immunol 54: 285-291.
16. Ho MH, Ho CK, Chong LY 2006. Atypical mycobacterial cutaneous infections in Hong Kong: 10-year retrospective study. Hong Kong Med J 12: 21-26.
17. Hogan LH, Macvilay K, Barger B, Co D, Malkovska I, Fennelly G, Sandor M 2001. Mycobacterium bovis strain bacillus Calmette-Guérin-induced liver granulomas contain a diverse TCR repertoire, but a monoclonal T cell population is sufficient for protective granuloma formation. J Immunol 166: 6367-6375.
18. Jarzembowski JA, Young MB 2008. Nontuberculous mycobacterial infections. Arch Pathol Lab Med 132: 1333-1341.
19. Khalil A, Bourut C, Halle-Pannenko O, Mathé G, Rappaport H 1975. Histologic reactions of the thymus, spleen, liver and lymph nodes to intravenous and subcutaneous BCG injections. Biomedicine 22: 112-121.
20. Ladel CH, Daugelat S, Kaufmann SH 1995. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to adquired resistance. Eur J Immunol 25: 377-384.
21. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 94: 5243-5248.
22. Mohan VP, Scanga CA, Yu K, Scott HM, Tanaka KE, Tsang E, Tsai MM, Flynn JL, Chan J 2001. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 69: 1847-1855.
23. Nigou J, Gilleron M, Rojas M, García LF, Thurnher M, Puzo G 2002. Mycobacterial lipoarabinomannans: modulators of dendritic cell function and the apoptotic response. Microbes Infect 4: 945-953.
24. Orrell JM, Brett SJ, Ivanyi J, Coghill G, Grant A, Beck JS 1992. Morphometric analysis of Mycobacterium tuberculosis infection in mice suggests a genetic influence on the generation of the granulomatous inflammatory response. J Pathol 166: 77-82.
25. Palwade PK, Dhurat RS, Tendolkar UM, Dethe GR, Jerajani HR 2006. Chronic cutaneous disease caused by the rapid growers Mycobacterium fortuitum and chelonae. Br J Dermatol 154: 774-775.
26. Parti RP, Srivastava S, Gachhui R, Srivastava KK, Srivastava R 2005. Murine infection model for Mycobacterium fortuitum. Microbes Infect 7: 349-355.
27. Runyon EH 1959. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 43: 273-290.
28. Russell DG, Mwandumba HC, Rhoades EE 2002. Mycobacterium and the coat of many lipids. J Cell Biol 158: 421-426.
29. Sato IY, Kobayashi K, Kasama T, Kaga S, Kasahara K, Kanemitsu H, Nakatani K, Takahashi T, Nakamura RM, Skamene E, Yoshida T 1990. Regulation of Mycobacterium bovis BCG and foreign body granulomas in mice by the Bcg gene. Infect Immun 58: 1210-1216.
30. Sungkanuparph S, Sathapatayavongs B, Pracharktam R 2003. Rapidly growing mycobacterial infections: spectrum of diseases, antimicrobial susceptibility, pathology and treatment outcomes. J Med Assoc Thai 86: 772-780.
31. Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW 2006. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment and susceptibility. Arch Dermatol 142: 1287-1292.
32. van der Sar AM, Abdallah AM, Sparrius M, Reinders E, Vandenbroucke-Grauls CM, Bitter W 2004. Mycobacterium marinum strains can be divided into two distinct types based on genetic diversity and virulence. Infect Immun 72: 6306-6312.
33. Vercellone A, Nigou J, Puzo G 1998. Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis. Front Biosci 3: 149-163.
34. Weitzul S, Eichhorn PJ, Pandya AG 2000. Nontuberculous mycobacterial infections of the skin. Dermatol Clin 18: 359-377.
35. Zhu G, Xiao H, Mohan VP, Tanaka K, Tyagi S, Tsen F, Salgame P, Chan J 2003. Gene expression in the tuberculous granuloma: analysis by laser capture microdissection and real-time PCR. Cell Microbiol 5: 445-453.